Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230253402> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4230253402 abstract "Abstract BackgroundTo evaluate the efficacy and safety of erythropoietin (Epo) combined with therapeutic hypothermia (TH) in neonatal hypoxic-ischemic encephalopathy (HIE).MethodsA total of 78 term infants with HIE were assigned randomly to receive Epo (n = 40) or placebo (n = 38). All infants received TH. Blood samples before TH, after TH and after Epo/placebo were collected for measuring TH associated adverse events, Epo associated factors and potential neural biomarkers. Basal ganglia/ watershed (BG/W) scoring system was used to assess brain injury in MRI. Neurodevelopmental evaluations were performed at 18 months by using BayleyScales of Infant Development II (Bayley II).ResultsEpo-treated group tend to have lower serum creatine kinase (CK) concentration (114 vs 202, P = .04) and higher serum K + , Mg 2+ concentration (5.0 vs 4.5, P = .03; 1.0 vs 0.9, P = .02) than control group after intervention. Brain MRI was performed in 65 (83%) neonatal. Totally brain injury score was in even distribution between two groups (median, 0 vs 0, P = .61), but injury region in cortex plus basal nuclei comparing with in basal nuclei solely was less common in the Epo than in the control group (21% vs 31%, P = .046). Only forty patients (40/78, 51%) succeeded in achieving 18-month follow up data. The totally adverse outcomes were trend to decline in the Epo group (35% vs 60%, P = .21). No adverse events were ascribed to Epo treatment.ConclusionsThe combination of Epo and TH is proved to be feasible, safe and potential effective.Trial registration: ChiCTR-TRC-14004532, date of registration: April 18th, 2014." @default.
- W4230253402 created "2022-05-11" @default.
- W4230253402 creator A5000059716 @default.
- W4230253402 creator A5003807314 @default.
- W4230253402 creator A5019081064 @default.
- W4230253402 creator A5029360035 @default.
- W4230253402 creator A5070522623 @default.
- W4230253402 creator A5073216008 @default.
- W4230253402 creator A5076140952 @default.
- W4230253402 creator A5080732301 @default.
- W4230253402 date "2020-05-13" @default.
- W4230253402 modified "2023-09-29" @default.
- W4230253402 title "Is Erythropoietin Combining with Therapeutic Hypothermia an Efficient and Safe Therapy in Neonatal Hypoxic Ischemic Encephalopathy: A Prospective and Randomized Clinical Trial" @default.
- W4230253402 doi "https://doi.org/10.21203/rs.3.rs-26962/v1" @default.
- W4230253402 hasPublicationYear "2020" @default.
- W4230253402 type Work @default.
- W4230253402 citedByCount "0" @default.
- W4230253402 crossrefType "posted-content" @default.
- W4230253402 hasAuthorship W4230253402A5000059716 @default.
- W4230253402 hasAuthorship W4230253402A5003807314 @default.
- W4230253402 hasAuthorship W4230253402A5019081064 @default.
- W4230253402 hasAuthorship W4230253402A5029360035 @default.
- W4230253402 hasAuthorship W4230253402A5070522623 @default.
- W4230253402 hasAuthorship W4230253402A5073216008 @default.
- W4230253402 hasAuthorship W4230253402A5076140952 @default.
- W4230253402 hasAuthorship W4230253402A5080732301 @default.
- W4230253402 hasBestOaLocation W42302534021 @default.
- W4230253402 hasConcept C103728769 @default.
- W4230253402 hasConcept C118552586 @default.
- W4230253402 hasConcept C126322002 @default.
- W4230253402 hasConcept C142724271 @default.
- W4230253402 hasConcept C164953862 @default.
- W4230253402 hasConcept C168563851 @default.
- W4230253402 hasConcept C169900460 @default.
- W4230253402 hasConcept C197934379 @default.
- W4230253402 hasConcept C204787440 @default.
- W4230253402 hasConcept C27081682 @default.
- W4230253402 hasConcept C2777390192 @default.
- W4230253402 hasConcept C2778024521 @default.
- W4230253402 hasConcept C2778080812 @default.
- W4230253402 hasConcept C2778534260 @default.
- W4230253402 hasConcept C2778621155 @default.
- W4230253402 hasConcept C2779306644 @default.
- W4230253402 hasConcept C2909832856 @default.
- W4230253402 hasConcept C42219234 @default.
- W4230253402 hasConcept C71924100 @default.
- W4230253402 hasConceptScore W4230253402C103728769 @default.
- W4230253402 hasConceptScore W4230253402C118552586 @default.
- W4230253402 hasConceptScore W4230253402C126322002 @default.
- W4230253402 hasConceptScore W4230253402C142724271 @default.
- W4230253402 hasConceptScore W4230253402C164953862 @default.
- W4230253402 hasConceptScore W4230253402C168563851 @default.
- W4230253402 hasConceptScore W4230253402C169900460 @default.
- W4230253402 hasConceptScore W4230253402C197934379 @default.
- W4230253402 hasConceptScore W4230253402C204787440 @default.
- W4230253402 hasConceptScore W4230253402C27081682 @default.
- W4230253402 hasConceptScore W4230253402C2777390192 @default.
- W4230253402 hasConceptScore W4230253402C2778024521 @default.
- W4230253402 hasConceptScore W4230253402C2778080812 @default.
- W4230253402 hasConceptScore W4230253402C2778534260 @default.
- W4230253402 hasConceptScore W4230253402C2778621155 @default.
- W4230253402 hasConceptScore W4230253402C2779306644 @default.
- W4230253402 hasConceptScore W4230253402C2909832856 @default.
- W4230253402 hasConceptScore W4230253402C42219234 @default.
- W4230253402 hasConceptScore W4230253402C71924100 @default.
- W4230253402 hasLocation W42302534021 @default.
- W4230253402 hasOpenAccess W4230253402 @default.
- W4230253402 hasPrimaryLocation W42302534021 @default.
- W4230253402 hasRelatedWork W12160871 @default.
- W4230253402 hasRelatedWork W13148500 @default.
- W4230253402 hasRelatedWork W17136736 @default.
- W4230253402 hasRelatedWork W19658824 @default.
- W4230253402 hasRelatedWork W21310257 @default.
- W4230253402 hasRelatedWork W3090854 @default.
- W4230253402 hasRelatedWork W3692456 @default.
- W4230253402 hasRelatedWork W5032858 @default.
- W4230253402 hasRelatedWork W8129469 @default.
- W4230253402 hasRelatedWork W6918129 @default.
- W4230253402 isParatext "false" @default.
- W4230253402 isRetracted "false" @default.
- W4230253402 workType "article" @default.